GT Biopharma Other Long Term Liabilities (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.45 -0.01 (-2.17%) USD | NASDAQ | Feb 23, 16:00

0.4286 -0.02 (-4.76%) After-Hours: 19:59

View Other Long Term Liabilities (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

SELLAS Life Sciences Group, Inc.	--
Lyell Immunopharma, Inc.	Upgrade
Geron Corp.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade